Technology Transfer
Additional Topics
in This Section
The Office of Corporate Alliances (OCA) supports the mission of Fox Chase Cancer Center to accelerate the integration of emerging technologies into team-based science to reduce the burden of cancer in all individuals by facilitating relationships with industry in order to translate clinical and basic research findings into products and services for the public good.
With annual research expenditures that approximate $100 million, Fox Chase Cancer Center is one of the leading freestanding cancer research and treatments centers in the United States.
Research and Technology Symposium Tuesday May 20
|
During the Symposium, researchers provided an overview of Fox Chase's broad array of nationally competitive basic, translational, and clinical research, including its special programs in cancer prevention, detection and treatment. See slide presentations from the Agenda for the Day. Research topics presented during the Symposium included:
Along with the research projects mentioned below, a poster session during the lunch hour displayed technologies (e.g., molecular diagnostics, therapeutics, vaccines, devices, and research tools) available for licensing. For more information, contact the Fox Chase Office of Corporate Alliances. |

Print this Page
E-mail This Page